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Abstract
Associations between the central serotonergic and γ-aminobutyric acid (GABA) systems play key roles in
the prefrontal cortical regulation of emotion and cognition and in the pathophysiology and pharmaco-
therapy of highly prevalent psychiatric disorders. The goal of this study was to test the effects of common
variants of the tryptophan hydroxylase isoform 2 (TPH2) gene on GABA concentration in the prefrontal
cortex (PFC) using magnetic resonance spectroscopy. In this study involving 64 individuals, we examined
the associations between prefrontal cortical GABA concentration and 12 single nucleotide polymorphisms
(SNPs) spanning the TPH2 gene, including rs4570625 (−703 G/T SNP), a potentially functional TPH2
polymorphism that has been associated with decreased TPH2 mRNA expression and panic disorder.
Our results revealed a signiﬁcant association between increased GABA concentration in the PFC and the
T-allele frequencies of two TPH2 SNPs, namely rs4570625 (−703 G/T) and rs2129575 (p40.0004) and the
C-allele frequency of one TPH2 SNP, namely rs1386491 (p=0.0003) in female subjects. We concluded
that rs4570625 (−703 G/T), rs2129575 and rs1386491 play a signiﬁcant role in GABAergic neuro-
transmission and may contribute to the sex-speciﬁc dysfunction of the GABAergic system in the PFC.
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Introduction
The neurotransmitter serotonin (5-hydroxytryptamine;
5-HT) is one of the key modulators of the brain’s
circuits for emotion and adaptation to stress.
Associations have been found between different
neuropsychiatric disorders and the genes that modu-
late serotonergic neurotransmission, such as the
TPH2 gene, which encodes for tryptophan hydroxylase
isoform 2, an enzyme exclusively expressed in the
brain (Maron et al., 2007; Gutknecht et al., 2009;
Roche and McKeon, 2009). Tryptophan hydroxylase,
which is the rate-limiting enzyme in 5-HT synthesis,
catalyses the hydroxylation of tryptophan. One of the
major target structures of the central serotonergic
system is the prefrontal cortex (PFC). Selective 5-HT
reuptake inhibitors (SSRIs) can signiﬁcantly increase
brain γ-aminobutyric acid (GABA) concentration
(Bhagwagar et al., 2004); suggesting that altering
5-HT concentration will have a direct impact on
GABA concentration. However, it should be noted
that Bhagwagar et al. (2004) observed GABA concen-
tration in the occipital cortex. Evidence regarding
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possible effects of SSRIs on GABA levels in the PFC is
still missing. Glutamatergic pyramidal neurons and
GABA interneurons are the two major neuronal popu-
lations in the PFC. GABAergic interneurons exert
powerful inhibitory control over excitatory efferent
projections from the PFC (Feng et al., 2001). The
main effect of physiologically released 5-HT on these
PFC projections is inhibitory (Puig et al., 2005).
Serotonergic axons synapse predominantly on inter-
neurons (Smiley and Goldman-Rakic, 1996), and
5-HT can strongly modulate GABA-mediated inhibi-
tory neurotransmission (Ciranna, 2006). The psychia-
tric conditions associated with impaired serotonergic
neurotransmission are also associated with a dysfunc-
tional GABA system. Schizophrenia, depression and
anxiety have been associated with reduced cortical
GABA concentration (Akbarian et al., 1995; Sanacora
et al., 1999; Goddard et al., 2001; Hasler et al., 2007,
2010). Speciﬁcally, anxiety disorders have been associ-
ated with low GABA concentration in the PFC
(Goddard et al., 2001; Hasler, 2010; Hasler et al.,
2010). Moreover, the GABA system is the target of
novel antidepressants and mood-stabilizing treatments
(Krystal et al., 2002). SSRIs that produce antidepressant
and anxiolytic effects have been shown to increase the
ﬁring rates of GABA interneurons (Zhong and Yan,
2011) and, as mentioned earlier, increase brain GABA
concentration (Bhagwagar et al., 2004). Taken together,
these data suggest that the 5-HT×GABA interactions
within the PFC play a key role in the prefrontal cortical
regulation of emotion and cognition and in the patho-
physiology and pharmacotherapy of highly prevalent
psychiatric disorders.
Human variants of TPH2 have been related to
anxiety-related traits (Waider et al., 2011), amygdala
reactivity (Brown et al., 2005; Canli et al., 2005) and
psychiatric disorders (Walitza et al., 2005; Mossner
et al., 2006b; Kim et al., 2009). However, the molecular
pathways that are affected by the TPH2 variants and
which result in the risk of psychiatric disorders have
not yet been elucidated. Low cortical GABA concen-
trations have been proposed as the most promising
imaging endophenotype in mood and anxiety dis-
orders (Hasler and Northoff, 2011).
We hypothesized that variations within the TPH2
gene signiﬁcantly inﬂuence prefrontal cortical GABA
concentration, as determined by magnetic resonance
spectroscopy (MRS). We examined the associations
between GABA concentration in the medial PFC and
12 single nucleotide polymorphisms (SNPs) spanning
the TPH2 gene, including rs4570625 (−703 G/T SNP).
Moreover, based on sex differences in 5-HT (5-HT
transporter and 5-HT1A and 5-HT2A receptors) and
brain GABA concentrations (Cosgrove et al., 2007),
we examined the associations in male and female sub-
jects separately. Kim et al. (2009) showed a signiﬁcant
association of rs4570625 with panic disorder (PD) in
women. This SNP is potentially functional given recent
evidence that the G allele is associated with decreased
TPH2 mRNA expression relative to the T allele
(Lin et al., 2007; Chen et al., 2008). The samples were
genotyped with a haplotype capture array developed
and described previously (Hodgkinson et al., 2008).
Conceivably, our results may help to elucidate the
molecular mechanisms that inﬂuence the serotonergic
regulation of GABAergic transmission within the PFC.
Method
Participants
Volunteers were recruited through newspaper adver-
tisements and posters displayed on the National
Institutes of Health, Bethesda campus under a protocol
that was approved by the Institutional Review Board
of the National Institute of Mental Health. All partici-
pants were evaluated for psychiatric diagnoses by
an unstructured clinical interview with a psychiatrist
as well as with a Structured Clinical Interview of
the Diagnostic and Statistical Manual of Mental
Disorders-IV and the Structured Interview Guides
for the Hamilton Depression Rating Scale and
Montgomery–Åsberg Depression Rating Scale. The
clinical evaluation involved a physical examination,
electrocardiography and laboratory tests, including
kidney and liver function tests, hematologic proﬁling,
thyroid function test, urinalysis and toxicology (drug
screen). Exclusion criteria were current medical or
neurological disorders, pregnancy, smoking and/or
substance abuse. Patients were not under psychotropic
medication for at least 4 wk prior to scanning.
All participants gave informed consent and the
study was approved by the Combined Neuroscience
Institutional Review Board at the National Institutes
of Health (Hasler et al., 2007).
The study population consisted of 64 individuals
from the following four diagnostic groups: healthy
controls [n=20; 15 women; aged (mean±S.D.) 36.9±
13.8 yr]; individuals with a current episode of major de-
pressive disorder (n=19; 12 women; aged 31.5±9 yr);
individuals with remitted major depressive disorder
(n=16; 12 women; aged 40.8±11.7 yr); individuals
with PD (n=9; 8 women; aged 33.8±12.8 yr). In indi-
viduals with PD, mean score (±S.D.) for the Panic
Disorder Severity Scale was 7.15±3.16, for the Panic
Symptom Scale 18.5±6.02 and for the Hamilton
Anxiety Scale 10.08±6.42.
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Magnetic resonance spectroscopy
We used in vivo proton MRS to assess the cerebral
GABA concentration. Participants underwent scanning
in a single session with a 3-T whole-body scanner and
a transmit–receive head coil (General Electric Medical
Systems, USA) that was capable of providing a homo-
geneous radio frequency ﬁeld and spectroscopic
measurements of the PFC.
Proton MRS spectra were acquired in a voxel (3×3×
2 cm3) positioned with the posterior edge 1mm anterior
to the rostrum of the corpus callosum and centred on
the midline in the horizontal plane and on the bicom-
missural line in the sagittal plane. This voxel included
portions of the perigenual anterior cingulate cortex
and the adjacent frontal polar cortex (i.e. portions of
Brodmann areas 24, 32 and 10; Hasler et al., 2010).
The unedited part of an interleaved position-
resolved spectroscopy sequence-based J editing
method (Sailasuta et al., 2001; Hasler et al., 2007,
2010) was used to measure the concentrations of
N-acetylaspartate, choline and creatine metabolites,
and the spectrum resulting from the subtraction of
the unedited and the edited spectra was used to
speciﬁcally measure the GABA concentration. Echo
time for this sequence was set to 68ms and a single
scan consisted of 1024 averages at a repetition time
of 1.5 s for a total scan time of 25.6min. The concen-
trations of GABA, which were referenced to the con-
centration of creatine, were expressed as mmol/l (mM).
In order to reference the spectra to a quantitative stan-
dard, the creatine concentration was set to 7.1mM,
which is the average creatine concentration in the
grey and white matter reported in the literature. This
conventional creatine referencing method, which is
well suited for this study because of the extremely
low turnover rate of total creatine in the brain (Wyss
and Kaddurah-Daouk, 2000), has been validated and
described previously (Shen et al., 2002; Sanacora
et al., 2003). In the current study, only the GABA:cre-
atine ratios were measured. Since the brain metabolism
of creatine is unrelated to tryptophan hydroxylase or
variations in the TPH2 gene, we believe that it is safe
to assume that creatine is not affected by variations
in TPH2 SNPs. Interleaved acquisition and careful
in vivo and in vitro quality control procedures were
employed in order to ensure the quality of the data.
No subtraction errors were detected between the
edited and unedited scans.
Genotyping
Peripheral blood was drawn from all 64 participants
and DNA was extracted with standard procedures.
Samples were genotyped with an addiction array,
which was developed by Hodgkinson et al. (2008).
This array was developed in order to include a panel
of markers that are able to provide full haplotype
information for the candidate genes of interest in
addictive and mood disorders. Our array included
the following 12 SNPs that span the TPH2 gene:
rs4570625; rs10748185; rs2129575; rs1386488; rs1843809;
rs1386496; rs2171363; rs1386491; rs6582078; rs1352250;
rs1487275; rs1386483. For all 64 participants, inform-
ation was available on ancestry informative markers
(AIMs). The ancestry of each subject was evaluated
separately in the context of the worldwide genetic fac-
tor structure. As a result, the AIMs were derived in a
consistent way in order to reﬂect any of the major
worldwide ancestry factors. We used 186 AIMs to
evaluate these individuals for the population stratiﬁca-
tion of GABA concentration. Each AIM was a SNP of a
known allele frequency in HapMap reference popu-
lations and a 6-factor solution was used to estimate
the ancestry with Structure version 2.0 (Falush et al.,
2003), as described previously (Zhou and Wang, 2008).
Statistics
Statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS) for Mac (version
19.0; IBM Corporation, USA). Allele frequencies are
provided in Table 1. We calculated pairwise linkage
disequilibrium (LD) between the SNPs with the SNP
Analyser 1.2 (Istech Corp., Korea). In order to describe
LD, we used the absolute value of D′. D′ values
and statistical signiﬁcance are provided in Table 2.
Multiple linear regressions for the number of minor
alleles were performed in order to examine the associ-
ation between GABA concentration and genotype at
each SNP. An additive genetic model was tested by
recoding the three SNP genotypes as 0 for the homo-
zygote of the common allele, 1 for the heterozygote
and 2 for the homozygote of the uncommon allele. In
order to keep type-I error at a rate <5%, we computed
the Šidák-corrected signiﬁcance threshold for multiple
testing of SNPs in LD with SNPSpD (Šidák, 1967;
Nyholt, 2004):
αp = 1− (1− αe)1/MeffLi (1)
The number of independent SNPs (MeffLi) was six and
the MeffLi-Šidák correction was 0.008. MeffLi was calcu-
lated using the following equation:
MeffLi =
∑M
i=1
f (|λi|)
f (x) =I(x5 1) + (x− x⌊ ⌋), x5 0
(2)
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where λi is the eigenvalue of c identical tests, I(x51) is
the indicator function and ⌊x⌋ is the ﬂoor function (for
detailed information see Li and Ji, 2005). Possible
effects of gender, age, diagnosis and ancestry on
GABA level were calculated with a stepwise linear
regression.
Results
We found signiﬁcant associations between prefrontal
GABA concentration and allele frequencies for the
rs4570625, rs2129575 and rs1386491 SNPs (p40.008;
Table 3). Rs4570625 (G/T polymorphism), rs2129575
(G/T polymorphism) and rs1386492 (C/G polymorph-
ism) signiﬁcantly predicted GABA concentration.
GABA levels increased with the number of T or C
alleles.
There were no signiﬁcant associations between gen-
der, age or psychiatric disorder with GABA concen-
tration (p>0.47, Fig. 1). Additionally, none of the
ancestry factors predicted GABA level (p>0.1).
Number of participants per genotype for rs4570625,
rs2129575 and rs1386492 is presented in Table 4. Due
to the small number of participants with the homo-
zygote of the uncommon allele, participants were
divided into two groups based on genotype for both
rs4570625 and rs2129575 for further analysis (see also
Canli et al., 2005). One group consisted of either one
or two copies of the T allele (T-carriers) and the other
group consisted of non-T-carriers. Similar groups
were built for rs1386492. One group consisted of either
one or two copies of the C allele (C-carriers) and the
other group consisted of non-C-carriers.
Given the important sex differences in the central
5-HT and GABA systems (Hasler and Northoff, 2011),
Table 2. D′ and p values for all combinations of TPH2 single nuclear polymorphisms (SNP)
SNP1 SNP2 SNP3 SNP4 SNP5 SNP6 SNP7 SNP8 SNP9 SNP10 SNP11 SNP12
SNP1 <0.0001 <0.0001 0.218 0.173 0.172 <0.0001 <0.0001 <0.0001 <0.0001 0.332 <0.0001
SNP2 1 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SNP3 0.913 0.889 0.368 0.24 0.098 <0.0001 <0.0001 <0.0001 <0.0001 0.031 <0.0001
SNP4 0.344 0.84 0.239 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.017
SNP5 0.421 0.83 0.343 0.827 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SNP6 0.458 0.772 0.52 0.933 1 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.03
SNP7 1 0.846 1 0.743 1 1 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SNP8 0.785 1 0.889 1 1 1 1 <0.0001 <0.0001 0.041 0.871
SNP9 0.782 0.842 0.876 0.814 0.767 0.869 0.957 1 <0.0001 <0.0001 <0.0001
SNP10 0.839 0.761 0.932 0.588 0.744 0.68 0.884 0.896 0.892 <0.0001 <0.0001
SNP11 0.086 0.503 0.189 0.325 0.492 0.484 0.798 0.201 0.645 0.928 <0.0001
SNP12 0.459 0.471 0.403 0.311 0.449 0.346 0.791 0.033 0.471 0.781 0.831
Table 1. Descriptive statistics of the 12 single nuclear polymorphisms (SNP)
SNP Chromosome Gene Location Polymorphism Allele frequency
SNP1 rs4570625 12 TPH2 70618190 G/T 0.73/0.27
SNP2 rs10748185 12 TPH2 70622122 A/G 0.42/0.58
SNP3 rs2129575 12 TPH2 70626340 G/T 0.71/0.29
SNP4 rs1386488 12 TPH2 70630885 A/C 0.79/0.21
SNP5 rs1843809 12 TPH2 70634965 G/T 0.18/0.82
SNP6 rs1386496 12 TPH2 70637057 C/T 0.16/0.84
SNP7 rs2171363 12 TPH2 70646531 C/T 0.47/0.53
SNP8 rs1386491 12 TPH2 70648645 C/G 0.22/0.78
SNP9 rs6582078 12 TPH2 70661158 G/T 0.45/0.55
SNP10 rs1352250 12 TPH2 70684051 A/G 0.52/0.48
SNP11 rs1487275 12 TPH2 70696559 G/T 0.27/0.73
SNP12 rs1386483 12 TPH2 70698761 A/G 0.6/0.4
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we tested the associations in male and female
participants separately. In an attempt to examine
the possible interactions of gender and genotype, we
used the SPSS macro Modprobe (Hayes and Matthes,
2009). The dependent variable was GABA level,
the focal predictor was the respective genotype
(rs4570625, rs2129575 and rs1386491) and the moder-
ator variable was gender.
The overall ﬁt of the ﬁrst model (rs4570625) was
highly signiﬁcant (R2=0.2, F=5.06, d.f.1=3, d.f.2=60,
p=0.003). Including the genotype×gender interaction
(b=0.013, S.E. =0.005, t=2.59, p=0.012) increased R2
signiﬁcantly (ΔR2=0.1, F=6.69, p=0.01). The mod-
erator variable, gender, did not predict GABA level
(b=−0.005, S.E. =0.004, t=−1.23, p=0.22). There was
a tendency for genotype to predict GABA level
(b=−0.017, S.E. =0.009, t=−1.83, p=0.07). Interestingly,
the conditional effects of the focal predictor revealed
a highly signiﬁcant effect of genotype on GABA level
in female participants (b=0.01, S.E. =0.003, t=3.72,
p=0.0004) but not in male participants (b=−0.004,
S.E. =0.005, t=−0.8, p=0.43). The T allele of rs4570625
Table 3. Association analysis of polymorphisms within
tryptophan hydroxylase isoform 2 (TPH2) and prefrontal
γ-aminobutyric acid (GABA) levels
Chr/Gene SNP
Linear regression with GABA
concentration (n=64)
TPH2 rs4570625 B=0.007; p=0.002; r2=0.14
rs10748185 B=0.002; p=0.21; r2=0.025
rs2129575 B=0.007; p=0.001; r2=0.159
rs1386488 B=−0.002; p=0.45; r2=0.009
rs1843809 B=−0.001; p=0.76; r2=0.002
rs1386496 B=−0.001; p=0.59; r2=0.005
rs2171363 B=−0.001; p=0.65; r2=0.003
rs1386491 B=0.006; p=0.008; r2=0.109
rs6582078 B=0.003; p=0.13; r2=0.036
rs1352250 B=−0.003; p=0.15; r2=0.032
rs1487275 B=0.000; p=0.86; r2=0.000
rs1386483 B=0.000; p=0.86; r2=0.000
The effects of seven single nuclear polymorphisms (SNPs)
were tested in 64 individuals by the linear regression of
minor allele occurrences on the magnetic resonance
spectroscopy-determined in vivo GABA concentrations.
Signiﬁcant association of the three SNPs, rs4570625,
rs2129575 and rs1386491 with the GABA levels survived
Bonferroni’s correction for multiple testing.
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Fig. 1. Relationships between prefrontal cortical
γ-aminobutyric acid (GABA) concentrations and (a) gender,
(b) psychiatric diagnosis and (c) age. None of these variables
was associated signiﬁcantly with GABA levels. Con, healthy
controls; MDD, major depressive disorder; rem-MDD,
remitted MDD; PD, panic disorder.
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was associated with higher prefrontal GABA concen-
tration in women (Fig. 2).
The overall ﬁt of the second model (rs2129575) was
highly signiﬁcant (R2=0.26, F=6.96, d.f.1=3, d.f.2=60,
p=0.0004). Including the signiﬁcant genotype×gender
interaction (b=0.016, S.E. =0.005, t=3.18, p=0.002) sig-
niﬁcantly improved R2 (ΔR2=0.12, F=10.09, p=0.002).
Genotype (b=−0.021, S.E. =0.009, t=−2.32, p=0.023)
signiﬁcantly predicted GABA level but gender
(b=−0.007, S.E. =0.004, t=−1.67, p=0.1) did not.
The conditional effects of the focal predictor depending
on the values of the moderator variable revealed that
the effects for genotype became signiﬁcant for female
participants (b=0.01, S.E. =0.003, t=4.33, p=0.0001) but
not for male participants (b=−0.005, S.E. =0.004,
t=−1.17, p=0.25). The T allele of rs2129575 was associ-
ated with increased prefrontal GABA concentration in
women (Fig. 3).
The overall ﬁt of the third model (rs1386491) was
highly signiﬁcant (R2=0.21, F=5.16, d.f.1=3, d.f.2=60,
p=0.003). Including the genotype×gender interaction
(b=0.01, S.E. =0.005, t=2.41, p=0.004) signiﬁcantly
improved R2 (ΔR2=0.08, F=5.83, p=0.02). Genotype
(b=−0.015, S.E. =0.009, t=−1.57, p=0.12) and gender
(b=−0.003, S.E. =0.004, t=−0.7, p=0.49) had no effect
on prefrontal GABA concentration. The conditional
effects of the focal predictor genotype depending on
the values of the moderator variable, gender, revealed
that the effects for genotype became signiﬁcant
for female participants (b=0.01, S.E. =0.003, t=3.82,
p=0.0003) but not for male participants (b=−0.002,
S.E. =0.004, t=−0.44, p=0.66; Fig. 4). The C allele
of rs1386491 was associated with higher prefrontal
GABA concentration in female participants.
Discussion
To our knowledge, this is the ﬁrst assessment of associ-
ations between genetic variations within the brain-
speciﬁc 5-HT-synthesizing enzyme gene TPH2 and
Table 4. Number of participants depending on genotype (GG,
GT, TT, CG, CC) and gender for the single nuclear
polymorphisms (SNP) rs4570625, rs2129575 and rs1386491
SNP Gender GG GT TT
rs4570625 Male 7 10 0
Female 24 22 1
Total 31 32 1
rs2129575 Male 6 11 0
Female 24 20 3
Total 30 31 3
GG CG CC
rs1386491 Male 8 7 2
Female 31 15 1
Total 39 22 3
*
n.s.
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Fig. 2. Association between γ-aminobutyric acid (GABA)
levels and the single nucleotide polymorphism rs4570625
that was analysed separately for male and female subjects.
The association between genotype and GABA level became
signiﬁcant for female subjects (* p=0.0004) but not for male
subjects (n.s., p=0.43).
*
n.s.
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Fig. 3. Association between γ-aminobutyric acid (GABA)
levels and the single nucleotide polymorphism rs2129575
that was analysed separately for male and female subjects.
The association between genotype and GABA level became
signiﬁcant for female subjects (* p=0.0001) but not for male
subjects (n.s., p=0.25).
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PFC GABA concentrations. Our results revealed a sig-
niﬁcant association between the T-allele frequencies of
two TPH2 SNPs [rs4570625 (−703 G/T) and rs2129575]
and the C-allele frequency of one SNP (rs1386491) and
increased GABA concentration in the PFC in female
subjects. Given the evidence for an association between
−703 G/T and TPH2mRNA expression, the ﬁndings of
this study suggest that this polymorphism exerts a
functional effect on GABAergic neurotransmission in
the PFC and that this may contribute to deﬁcits in
GABAergic system function that have been reported
in patients with PD and other highly prevalent psy-
chiatric conditions.
The T allele of the SNP rs4570625 (−703 G/T) has
been associated with different psychopathological
disorders, such as schizophrenia (Fang et al., 2011),
suicidal behaviour in major depression (Yoon and
Kim, 2009), personality disorder and attention
deﬁcit/hyperactivity disorder (Jacob et al., 2010).
Furthermore, the T allele of the SNP rs4570625 (−703
G/T) has also been associated with low anxiety
levels (Gutknecht et al., 2007; Reuter et al., 2007).
Functional MRS imaging studies have shown relatively
increased haemodynamic activity in the amygdala in
response to negatively and positively valenced
emotional stimuli in T-allele carriers than in G-allele
homozygous individuals (Brown et al., 2005; Canli
et al., 2005). It is conceivable that this differential
haemodynamic responsiveness of the amygdala to
emotional stimuli is related to the differential GABA
concentrations in the PFC. Studies in humans and
experimental animals have shown that neural activity
in some medial PFC regions reduces outﬂow from
the central nucleus of the amygdala (Quirk et al.,
2003; Phelps et al., 2004; Sotres-Bayon and Quirk,
2010). The intra-synaptic GABA concentration is regu-
lated in part by the intracellular GABA concentration
(Jackson et al., 2000). Therefore, higher MRS-
determined GABA concentrations in both intracellular
and extracellular compartments would most likely be
associated with increased GABAergic transmission
within the medial PFC. If so, this higher inhibitory
transmission within the medial PFC might reduce
efferent prefrontal cortical transmission to the amyg-
dala, thereby diminishing the cortical modulation of
the amygdala response to emotional stimuli and poten-
tially producing effects like those observed (Brown
et al., 2005; Canli et al., 2005).
The T allele of rs4570625 (−703 G/T) is associated
with increased TPH2 mRNA expression in the raphe
nuclei where it catalyses the rate-limiting step in
5-HT synthesis (Lim et al., 2007). Thus, the T allele
presence may result in increased serotonergic neuro-
transmission to the PFC, which receives serotonergic
projections from the dorsal raphe nucleus. Serotonergic
axons synapse predominantly on GABAergic inter-
neurons in the PFC (Smiley and Goldman-Rakic,
1996) and the higher 5-HT transmission associated
with the administration of SSRIs increases both the
ﬁring rates of GABAergic interneurons (Zhong and
Yan, 2011) and the brain GABA concentrations
(Bhagwagar et al., 2004). Thus, the association between
the T allele and the increased TPH2 mRNA expression
in the raphe nuclei suggests a mechanism by which
this variant may result in the higher GABA concen-
trations found herein.
Several studies have shown that genetic variations
in TPH2 polymorphisms are associated with a number
of psychiatric disorders such as major depression,
suicide, anxiety and attention deﬁcit/hyperactivity dis-
orders (De Luca et al., 2004, 2005; Mouri et al., 2009;
Must et al., 2009). It has been hypothesized that dys-
function within the serotonergic system plays a major
role in anxiety disorders and that both SSRIs and
monoamine oxidase inhibitors show antipanic, anxio-
lytic and antidepressant effects in such disorders.
Unfortunately, we did not assess anxiety levels in sub-
jects with past or present major depressive disorder
and healthy controls. However, it is important to
note that Hasler et al. (2009) did not ﬁnd any relation-
ship between PFC GABA concentration and current
anxiety levels.
*
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Fig. 4. Association between γ-aminobutyric acid (GABA)
levels and the single nucleotide polymorphism rs1386491
that was analysed separately for male and female subjects.
The association between genotype and GABA level became
signiﬁcant for female subjects (* p=0.0003) but not for male
subjects (n.s., p=0.66).
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A recent study could show that genetic variations
(including rs2129575) in the TPH2 gene may partly
account for variations in 5-HT synthesis in the orbito-
frontal cortex (Booij et al., 2012). Jacobsen et al. (2012)
reported reduced basal and stimulated levels of extra-
cellular 5-HT and increased frontal 5-HT2A receptors
in TPH2 R439H knockin mice. However, they did not
ﬁnd changes in basal extracellular prefrontal GABA
levels. Interestingly, a recent study in mice found
that brain 5-HT deﬁciency, resulting from TPH2 inacti-
vation, differentially affects GABAergic systems in lim-
bic regions (Waider et al., 2012). Moreover, genetic
studies have revealed an association between vari-
ations in the TPH2 gene and PD. Although Mössner
et al. (2006a) found no association between the two
SNPs [rs4570625 (−703 G/T) and rs4565946] of the
TPH2 gene and PD in a population from Germany,
Kim et al. (2009) found a signiﬁcantly lower frequency
of the T allele of the rs4570625 (−703 G/T) polymorph-
ism in PD patients than in healthy controls. Both these
previous studies focused on a single SNP and did not
examine the effects of genetic variations along the
entire length of the TPH2 gene.
The present study revealed that the C allele of
rs1386491 was associated with higher prefrontal
GABA concentration. Only a few studies have exam-
ined the association between psychiatric disorders
and rs1386491. One study reported an association
between the TPH2 risk haplotype GGTG (including
rs1386491) and borderline personality disorder,
suicidal behaviour and aggression score (Perez-
Rodriguez et al., 2010). The risk haplotype GGTG
(rs2171363, rs1386491, rs6582078 and rs1352250) was
ﬁrst identiﬁed by Zhou et al. (2005). Other studies
could not show an association between the TPH2
gene (including rs1386491) and suicidal behaviour
(Mouri et al., 2009; Must et al., 2009).
One limitation of the present study needs to be
mentioned. We did not ﬁnd any differences in GABA
concentration between the control subjects and the
other diagnostic groups, which may be because of
the small sample sizes of each diagnostic group
(Hasler et al., 2009). Nevertheless, the results showed
a strong relationship between variations of the TPH2
gene and prefrontal GABA concentration. This may
conﬁrm the importance of examining molecular
mechanisms rather than behavioural phenotypes,
given the relatively long passage from genes and
gene products to psychopathology and the complex
and heterogeneous genetic underpinnings of psycho-
logical traits (Hasler and Northoff, 2011).
Recent studies have suggested sex differences in the
GABA systems and in the neurotransmission of 5-HT
(Cosgrove et al., 2007). These molecular differences
have also been linked to the pathophysiology of
anxiety disorders, such as PD. PD is more prevalent
in women than in men (Weissman et al., 1997;
Grant et al., 2006). While male PD patients showed
abnormal 5-HT transporter availability in various
brain regions, there was no such abnormality in female
PD patients (Maron et al., 2011). Furthermore, treat-
ment with the SSRI sertraline showed superior efﬁcacy
in women than in men with PD (Clayton et al., 2006).
Finally, previous studies have found important sex
differences in the association between TPH2 variants
and PD (Maron et al., 2007; Kim et al., 2009). In par-
ticular, Kim et al. (2009) have found a signiﬁcant
association with rs4570625 in the female subgroup
only. These results are in line with our results
that showed strong associations between the three
TPH2 SNPs [rs4570625 (−703 G/T), rs2126575 and
rs1386491] with prefrontal GABA concentration in
female study participants.
One downside to the present study was the rela-
tively low number of male subjects, which may have
been a result of the heterogeneous mix of patient
groups and healthy subjects. However, it is important
to keep in mind that the association between the TPH2
gene and prefrontal GABA level became stronger
when male subjects were excluded and that the
descriptive data for male subjects goes in the reverse
direction than for female subjects. A power analysis
revealed that for rs4570625 a minimum of 297 male
participants would have been required to have an
80% chance to detect a signiﬁcant effect of genotype
on GABA. Furthermore, for rs2129575 a minimum of
187 and for rs1386491 a minimum of 1263 male sub-
jects would have been required. Hence, we cannot
exclude that a higher number of male participants
might have led to a reversed main effect in males or
may have cancelled out. However, it seems unlikely
that a larger male sample size would have revealed a
main effect for male subjects in the same direction as
for female subjects. The results provide evidence for
a sex-speciﬁc interconnection between the serotonergic
and GABAergic systems.
Taken together, the present data provided evidence
for a speciﬁc molecular mechanism involving the
interconnection between the serotonergic and the
GABAergic systems in the PFC, which may play
important roles in the pathophysiology of highly
prevalent psychiatric conditions. Moreover, our
results, when combined with previous evidence,
suggest that these molecular mechanisms contribute
to the sex differences in the epidemiology and clinical
characteristics of stress-related psychiatric disorders.
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